[1] 中国法布雷病专家协作组. 中国法布雷病诊疗专家共识(2021年版)[J]. 中华内科杂志, 2021,60(4):321-330. [2] Azevedo O, Cordeiro F, Gago M F, et al.Fabry disease and the heart: a comprehensive review[J]. International Journal of Molecular Sciences, 2021,22(9):1-36. [3] Weedon-Fekjær M S, Pihlstrøm H K, Weedon-Fekjær H, et al. Gastrointestinal symptoms in adults with Fabry disease and their associations with physical and mental health[J]. Bmc Gastroenterology, 2025,25(1):819-832. [4] Morales M, Cruz J, Brignani E, et al.Quality of life and unmet needs in patients with fabry disease: a qualitative study[J]. Orphanet Journal of Rare Diseases, 2024,19(1):389-401. [5] 黄晓蓉, 白春林. 双心医学的研究现状(J). 中西医结合心脑血管病杂志, 2024,22(2):313-316. [6] Azevedo O, Gago M F, Miltenberger-Miltenyi G, et al.Fabry disease therapy: state-of-the-art and current challenges[J]. International Journal of Molecular Sciences, 2020,22(1):206-222. [7] 姜江芬, 孙雅逊, 杨丽黎. 法布里病伴心肌肥厚及肾功能不全1例的护理(J). 护理与康复, 2021,20(3):1-4. [8] Liu Y, Li Y, Li P, et al.Effectiveness and safety of enzyme replacement therapy in the treatment of Fabry disease: a Chinese monocentric real-world study[J]. Orphanet Journal of Rare Diseases, 2024,19(1):422-433. [9] Pieroni M, Namdar M, Olivotto I, et al. Anderson-Fabry disease management: role of the cardiologist[J]. European Heart Journal, 2024,1395-1409(45). [10] Stefan S, Cristea I A, Szentagotai Tatar A, et al.Cognitive-behavioral therapy (CBT) for generalized anxiety disorder: Contrasting various CBT approaches in a randomized clinical trial[J]. Journal of Clinical Psychology, 2019,75(7):1188-1202. [11] Vaccarino V, Shah A J, Mehta P K, et al.Brain-heart connections in stress and cardiovascular disease: Implications for the cardiac patient[J]. Atherosclerosis, 2021,328:74-82. [12] 鄢超慧. 基于网络信息平台的护理干预对慢性心力衰竭患者院外体液管理中的应用及对患者心功能的影响[J]. 心血管病防治知识, 2022,12(36):69-71. |